The ARK normothermic perfusion system from EBERS was showcased during the TERMIS-AM conference that took place on August 29th-1st September in Milan, Italy. The company was present with a stand in the commercial exhibition of the conference. In addition, the company also participated in the Machine Perfusion Lab, which included two hands-off demonstration sessions where delegates of the congress had the possibility of seeing the ARK Kidney device in normal operation with porcine kidneys. The company was represented by its CEO, Pedro Moreo, and CTO, VĂctor AlastruĂ©.